Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?

  • 275 Accesses

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, Reinhardt R, Hepp T, Kirchhof P, Aleynichenko E, Ringleb P, Hacke W, Veltkamp R (2012) Continuous stroke unit electrocardiographic monitoring versus 24 h Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 43:2689–2694

  2. 2.

    Benbir G, Uluduz D, Ince B, Bozluolcay M (2007) Atherothrombotic ischemic stroke in patients with atrial fibrillation. Clin Neurol Neurosurg 109:485–490

  3. 3.

    Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E (2000) Cardioembolic versus non-cardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 10:39–43

  4. 4.

    Kim YD, Cha MJ, Kim J, Lee DH, Lee HS, Nam CM, Nam HS, Heo JH (2011) Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with non-valvular atrial fibrillation. Stroke 42:930–934

  5. 5.

    Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316

  6. 6.

    Chimowitz MI, Lynn MJ, Derdeyn CP et al (2011) Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993–1003

  7. 7.

    Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867

  8. 8.

    Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151

  9. 9.

    Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus Warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992

  10. 10.

    Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in non-valvular atrial fibrillation. N Engl J Med 365:883–891

  11. 11.

    Mega JL, Braunwald E, Wiviott SD et al (2012) Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 366:9–19

  12. 12.

    Flaker GC, Eikelboom JW, Shestakovska O et al (2012) Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin. The apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. Stroke 43:3291–3297

  13. 13.

    Alexander JH, Lopes RD, James S et al (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708

  14. 14.

    Azoulay L, Dell’aniello S, Simon T, Renoux C, Suissa S (2013) The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost 109: dx.doi.org/10.1160/TH12-08-0542

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Correspondence to Claudia Stöllberger.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Stöllberger, C., Bastovansky, A. & Finsterer, J. Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?. J Thromb Thrombolysis 36, 492–494 (2013). https://doi.org/10.1007/s11239-013-0884-1

Download citation

Keywords

  • Atrial Fibrillation
  • Dabigatran
  • Rivaroxaban
  • Apixaban
  • Posterior Cerebral Artery